A referral to a hematologist usually means something showed up in your blood work that your primary care doctor wants a specialist to evaluate. Most often, the trigger is an abnormal complete blood count, or CBC, which measures red cells, white cells, and platelets. Sometimes the referral comes after an unexpected clotting event, a suspicious protein detected on routine labs, or blood counts that refuse to normalize despite treatment. The reasons span a wide range, from straightforward iron-related problems to more complex bone marrow conditions, and understanding why you were referred can take some of the anxiety out of the process.
Abnormal Blood Counts Are the Most Common Trigger
The CBC is one of the most frequently ordered lab tests in medicine, and it catches a lot of things. When counts fall outside normal ranges, your primary care doctor runs through a mental checklist of common, reversible causes: nutritional deficiencies, dehydration, a recent infection, or a medication side effect. When those explanations don’t fit, or when the abnormality persists on repeat testing, a hematology consultation becomes reasonable. A practical framework published in the Mayo Clinic Proceedings walks non-hematologists through this decision, outlining diagnostic algorithms for conditions like anemia, low platelets, low white cells, and elevated counts in any of those lines, with the explicit goal of helping general practitioners figure out when a subspecialty referral is warranted and when it can safely be skipped.1PubMed Central. How to interpret and pursue an abnormal complete blood cell count in adults
In practical terms, a single slightly low hemoglobin reading in an otherwise healthy person who just donated blood probably doesn’t need a hematologist. But hemoglobin that keeps dropping without explanation, or a platelet count that’s persistently below the normal range, or a white cell count that climbs for no obvious reason? Those are the patterns that generate referrals. The underlying concern isn’t always cancer. It’s that the body’s blood-production machinery might not be working properly, and figuring out why often requires specialized testing that goes beyond what a general practice can offer.
Red Blood Cell Problems
Anemia is among the top reasons people see a hematologist, but not all anemia requires one. Iron deficiency from a poor diet or heavy menstrual periods is usually managed by your regular doctor. The cases that get referred tend to involve unexplained or treatment-resistant anemia, or anemias caused by the body destroying its own red blood cells. Hemolytic anemia, where red cells break apart prematurely, is a category that should be referred to hematology for investigation, since the underlying cause can range from inherited membrane defects to autoimmune destruction. Early recognition and management by the referring physician matters, but the workup often requires specialized lab tests that hematologists are best equipped to interpret.2PubMed Central. How to approach haemolysis: Haemolytic anaemia for the general physician
On the opposite end of the spectrum, too many red blood cells can also land you in a hematologist’s office. Polycythemia vera is a condition where the bone marrow overproduces red cells, thickening the blood and raising the risk of clots and strokes. The diagnostic approach to this disease was substantially revised by the discovery that a specific mutation called JAK2 V617F is present in more than 90% of cases.3Blood. JAK2 V617F Mutation Testing in Polycythemia Vera: Use and Impact in a Single Academic Practice If your blood work shows a persistently elevated red cell mass, your doctor may order that genetic test before or alongside the hematology referral. A positive result essentially confirms the diagnosis, and the hematologist takes over management from there, typically with periodic blood draws to keep the count in a safe range and medications to reduce clotting risk.
Platelet Disorders, Both High and Low
Platelets are the tiny cell fragments responsible for clotting. When the count drops below normal, a condition called thrombocytopenia, you bruise easily and may bleed from the gums or nose without much provocation. Many cases have straightforward explanations: a viral illness, liver disease, or a medication side effect. But when the cause isn’t obvious, or when counts drop low enough to pose a bleeding risk, hematology gets involved.
Drug-induced thrombocytopenia is a particularly tricky diagnosis. Hospitalized patients take many medications and have other conditions that can independently lower platelets, making it hard to pin the drop on a specific drug. Specialized lab tests exist to confirm the diagnosis, and treatment involves stopping the offending medication. Platelet counts usually start recovering after four or five half-lives of the responsible drug. In severe cases with active bleeding, high-dose intravenous immunoglobulin can be given as a bridge.4PubMed Central. Drug-associated thrombocytopenia Identifying the culprit drug is the hematologist’s main contribution here, because getting it wrong means the patient stays at risk.
High platelet counts, called thrombocytosis, can be reactive, meaning the body is producing extra platelets in response to infection, inflammation, or iron deficiency, or they can signal a primary bone marrow disorder. A hematologist sorts out which scenario applies and, if it’s a primary disorder, begins monitoring or treatment.
Blood Clots in Unusual Locations
Most people associate blood clots with the legs (deep vein thrombosis) or the lungs (pulmonary embolism), and those are commonly managed by internists or emergency physicians. Hematologists enter the picture when clots form in unusual places or when there’s a suspected inherited clotting disorder driving the problem. Blood clots in the brain, liver, portal vein, spleen, gut, or kidneys each have unique presentations and workup requirements. A practical review in the European Journal of Haematology notes that thrombosis of unusual venous sites makes up a large part of consultative hematology and that these cases have distinct pathophysiology, provoking factors, and treatments compared to the more routine leg and lung clots.5PubMed. Venous thrombosis in unusual sites: A practical review for the hematologist
You might also be referred if you’ve had recurrent clots without a clear trigger, or if you had a clot at a young age, or if there’s a strong family history of clotting problems. The hematologist’s job in these situations is to check for inherited or acquired conditions that make your blood too prone to clotting, such as Factor V Leiden, antiphospholipid syndrome, or protein C and S deficiencies, and to advise on how long you should stay on blood thinners.
Bone Marrow Disorders
Some referrals happen because your doctor suspects a problem not just with a single type of blood cell, but with the factory that produces them all: the bone marrow. Myelodysplastic syndromes, or MDS, are a group of conditions where the marrow produces defective blood cells, leading to persistent low counts across one or more cell lines. The gold standard for diagnosis is a bone marrow examination, which evaluates whether cells look abnormal and what percentage are immature blasts. Genetic testing of the marrow sample is also part of the workup.6Haematologica. Diagnosis of myelodysplastic syndromes: the classic and the novel
Researchers are working on ways to reduce unnecessary biopsies. One approach involves integrating routine lab values and genetic analyses from a blood draw to create a screening score that predicts which patients with low counts actually need a marrow exam and which can safely avoid the procedure. Predictors of MDS include significant anemia, very low neutrophil or platelet counts, elevated red cell distribution width, and certain gene mutations.7Blood. Development and Validation of A Biopsy-Free Scoring System for Screening Myelodysplastic Syndrome (MDS) and Associated Diseases in Cytopenic Patients These tools aren’t yet standard practice everywhere, but they reflect a broader trend toward sparing patients from invasive procedures when the pre-test probability is low.
Suspicious Proteins in Your Blood
A serum protein electrophoresis, sometimes abbreviated SPEP, is a test that separates the proteins in your blood by electrical charge. When it reveals a monoclonal spike, meaning a single type of antibody is being overproduced, it raises the question of a plasma cell disorder. The spectrum runs from MGUS (monoclonal gammopathy of undetermined significance), which is common and usually harmless, through smoldering myeloma, to full-blown multiple myeloma, a bone marrow cancer.
Distinguishing between these conditions and determining who needs treatment versus monitoring is squarely in the hematologist’s domain.8PubMed Central. Does my patient with a serum monoclonal spike have multiple myeloma? MGUS is found incidentally in a meaningful fraction of older adults who have blood work for unrelated reasons, so finding a monoclonal protein does not automatically mean you have cancer. But it does mean ongoing surveillance is warranted, because a small percentage of MGUS cases progress to myeloma each year.
This kind of finding sometimes surfaces in unexpected clinical settings. A study of hip fracture patients found that abnormal SPEP results were common enough that orthogeriatric and hematology teams developed an algorithm to triage which patients actually warranted a hematology review.9Age and Ageing. 295 SPEP IT UP! Developing an algorithm for abnormal serum plasma electrophoresis results in hip fracture patients The takeaway for you as a patient: if you’re told you have an abnormal protein in your blood, it’s worth seeing a hematologist to get it properly classified, but don’t assume the worst before that evaluation happens.
Elevated Ferritin and Iron Overload Questions
Ferritin is a protein that stores iron, and a high ferritin level on routine labs often prompts a referral. The wrinkle is that ferritin doesn’t just go up when you have too much iron. It also rises during infections, inflammation, liver disease, and a variety of chronic conditions. In routine practice, only about 10% of cases of elevated ferritin are actually related to an iron overload; the remaining 90% reflect some other underlying process.10PubMed Central. Hyperferritinemia-A Clinical Overview
This distinction matters because the treatment for true iron overload, which can include therapeutic phlebotomy (regular blood removal) or chelation therapy, is quite different from treating the inflammation that falsely elevates the number. A hematologist can help sort this out using additional iron studies, liver imaging, and sometimes genetic testing for hereditary hemochromatosis. If your primary care doctor flagged a high ferritin and sent you to hematology, the specialist’s first goal will be figuring out whether the iron itself is the problem or whether the ferritin is acting as a marker for something else entirely.
When Medications Cause Blood Problems
Drugs can disrupt nearly every line of blood cell production and function. The list of possible drug-induced hematologic syndromes is long: hemolytic anemias, aplastic anemia, neutropenia, immune-mediated platelet destruction, clotting abnormalities, and even drug-related myelodysplasia. Older drugs with well-known blood toxicity profiles have been partly replaced by newer agents, including biologics, which come with their own set of unintended hematologic side effects.11PubMed Central. Drug-Induced Hematologic Syndromes
A referral in this context usually means your doctor is concerned that a medication you’re taking is affecting your blood counts and wants a specialist to confirm the connection, rule out other causes, and advise on whether to stop the drug. Chemotherapy patients are an obvious example, as blood count monitoring is routine and expected. But it also happens with less obvious culprits: certain antibiotics, seizure medications, rheumatologic drugs, and even over-the-counter supplements at high doses. The hematologist’s value here is in confidently attributing the blood changes to the drug versus uncovering an independent problem that just happened to surface while you were taking it.
Autoimmune Diseases With Blood Involvement
Systemic lupus erythematosus, or lupus, is an autoimmune condition that frequently produces hematologic abnormalities. In one study at a tertiary center, anemia was present in 98% of lupus patients at initial presentation, leukopenia in 92%, lymphopenia in 85%, and low platelets in 38%.12PubMed Central. Clinical and Hematological Manifestations of Systemic Lupus Erythematosus at Initial Presentation in a Tertiary Healthcare Center The blood abnormalities in lupus can result from chronic inflammation, immune destruction of blood cells, or the disease itself suppressing marrow function. In younger patients, anemia is the most commonly seen cytopenia, with autoimmune hemolytic anemia and anemia of chronic disease each accounting for a significant proportion of cases.13PubMed. Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia
If you have lupus and are referred to a hematologist, it’s often because your blood counts have dropped to levels that need specialized management, or because it’s unclear whether the cytopenia is driven by the lupus itself or by the medications used to treat it. This kind of overlap between rheumatology and hematology is common, and the two specialties frequently co-manage patients. Other autoimmune and inflammatory conditions, including rheumatoid arthritis, inflammatory bowel disease, and celiac disease, can similarly produce blood abnormalities that sometimes need hematologic input.
Pregnancy-Related Referrals
Low platelets during pregnancy are relatively common and usually benign. Gestational thrombocytopenia, the most frequent cause, accounted for about 29% of cases in a five-year analysis at a tertiary center, and these patients tended to have milder drops in platelet counts. Immune thrombocytopenic purpura (ITP), by contrast, caused more significant drops. Overall, 15% of pregnancies complicated by thrombocytopenia resulted in a hematology consultation, with the majority of those being for ITP. Among pregnancies with ITP, those who saw a hematologist had lower platelet nadirs but also higher rates of treatment, suggesting the consultation led to more active management.14PubMed. Thrombocytopenia in Pregnancy: A 5-Year Analysis of Characteristics and Practices From a Tertiary Academic Center
If you’re pregnant and your platelet count drops, your obstetrician will consider whether the timing and severity point toward benign gestational thrombocytopenia or something that needs further evaluation. A hematology referral during pregnancy doesn’t automatically mean there’s a serious problem, but it does mean your care team wants the diagnosis nailed down, especially if epidural anesthesia or surgical delivery is being considered, because severely low platelets raise the risk of bleeding during those procedures.
Unexplained Splenomegaly
An enlarged spleen found on imaging or physical exam can trigger a hematology referral, particularly when the cause isn’t apparent. The spleen filters blood and recycles old red cells, so many blood disorders make it enlarge. But infections, liver disease, and certain storage disorders can do the same thing. When initial workup by the primary care doctor or gastroenterologist doesn’t yield an answer, a hematologist may pursue more targeted testing.
A case report illustrates why this matters: a 38-year-old man presented with vague abdominal discomfort and night sweats after traveling abroad, with massive splenomegaly as his only prominent finding. Extensive initial investigations were inconclusive, and he was ultimately transferred to a tertiary center where a splenic biopsy revealed diffuse large B-cell lymphoma.15PubMed Central. Splenomegaly in the returning traveller: a diagnostic workup This isn’t meant to scare anyone with an enlarged spleen. The point is that when simpler explanations have been excluded, hematology has the tools and experience to dig deeper, including bone marrow biopsies and specialized imaging, to find answers that other specialties might miss.
What to Expect at the Hematologist’s Office
If you’ve never seen a hematologist, the appointment typically starts with a thorough review of your blood work, medical history, medications, and family history. Many referrals are resolved with additional blood tests ordered by the specialist, things like iron studies, reticulocyte counts, peripheral blood smears examined under a microscope, flow cytometry to characterize cell types, or genetic tests for specific mutations.
In some cases, a bone marrow biopsy is recommended. This involves inserting a needle into the back of the hip bone to extract a small sample of marrow. It sounds worse than it is for most people. Local anesthesia numbs the area, and the procedure takes about 15 to 20 minutes. A comparison study of bone marrow evaluation methods found that biopsy had a diagnostic accuracy of about 99%, far exceeding the aspirate alone at roughly 78%.16PubMed Central. Comparison of bone marrow aspirate cytology, touch imprint cytology and trephine biopsy for bone marrow evaluation This is why hematologists use all three preparations (aspirate, touch imprint, and biopsy core) together when they sample the marrow: each catches things the others miss.
Not every hematology visit involves a biopsy, though. Many patients are monitored with blood tests alone, sometimes for years, particularly those with stable conditions like MGUS or mild cytopenias that don’t require treatment. The frequency of follow-up visits depends entirely on your specific situation.
Transitioning From Pediatric to Adult Hematology
If you or your child has a chronic blood disorder like sickle cell disease, the shift from pediatric to adult hematology care is a real challenge. A survey of physicians who treat sickle cell patients found that 94% considered patient education about the transition “important” or “very important.” The primary barriers identified were patients’ knowledge about their own disease and their ability to navigate the adult healthcare system.17PubMed Central. Transitioning Adolescents With Sickle Cell Disease From Pediatric to Adult Care: Results From a New Survey of Health Care Professionals Roughly 41% of surveyed physicians used the Got Transition model, about 35% used a biopsychosocial model, and about a quarter didn’t use any established framework at all.
The practical consequence of a bumpy transition is that young adults can fall through the cracks, missing appointments and ending up in emergency rooms with crises that might have been prevented with consistent outpatient care. If your teenager has a hematologic condition, asking the pediatric hematologist about a formal transition plan well before the actual switch, ideally starting around age 14 or 15, can make the handoff significantly smoother. Many academic centers now have dedicated transition coordinators, though availability varies widely by region and condition.